More than $55 billion will be awarded to states and localities through settlements from pharmaceutical companies and others involved in the distribution and sale of prescription opioids.

States are in different phases of establishing administrative structures, distributing funding, and evaluating the impact of opioid settlement investments, ultimately working to improve infrastructure to meet substance use care demands and decrease opioid overdose deaths.

Explore these resources to see state-by-state progress toward the spending of settlement funding, best practices for administering settlement funding, and examples of how settlement investments are advancing key priorities in the substance use field.